基本信息
浏览量:1
职业迁徙
个人简介
Richard obtained a BSc. in Biology, and an MSc. (Distinction) in Oncology from Nottingham University before completing his PhD in Leeds, applying proteomics to study renal cell carcinoma and developing methods for identifying tumour markers and antigens.
Moving to Manchester for his post-Doc, he developed methods for the proteomic analysis of leukaemic and normal haematopoietic cell and stem cell (phospho)proteomes, establishing mass spectrometry for large scale relative protein quantification and phosphorylation site mapping. During this time, he developed the MIDAS (MRM-Initiated Detection and Sequencing) workflow for the sensitive detection of post-translational modifications, including phosphorylation, acetylation and proline hydroxylation. This workflow was extended to include relative and 'absolute' quantification of post-translational modification levels between samples, and is useful for the sensitive detection of any peptide, particularly in establishing MRM/SRM-type assays for biomarker validation workflows.
In 2011, he took up the post of Proteomics Lead at Central Manchester NHS Foundation Trust as part of the Centre for Advanced Discovery and Experimental Therapeutics (CADET), a joint venture with The University of Manchester. The Centre primarily focussed on the discovery of novel targets for therapeutic intervention, to define key pathways in disease progression, and extend these studies into the development and characterisation of novel therapeutics. As well as standard -omics-type analysis, Richard developed assays for targeted quantification of proteins and small molecules, providing data on pharmacokinaetics on both new and existing medications, and allowing the analysis of novel disease biomarkers in large sample cohorts.
In April 2017, Richard moved back to The University of Manchester to take up a Research Fellowship position in order to pursue his own research into how protein expression levels are altered in diseases, primarily in neurodegenerative disorders such as Alzheimer's Disease.
In April 2019, he was awarded a Senior Lectureship and became Deputy Diector of the Stoller Biomarker Discovery Centre (link)
Moving to Manchester for his post-Doc, he developed methods for the proteomic analysis of leukaemic and normal haematopoietic cell and stem cell (phospho)proteomes, establishing mass spectrometry for large scale relative protein quantification and phosphorylation site mapping. During this time, he developed the MIDAS (MRM-Initiated Detection and Sequencing) workflow for the sensitive detection of post-translational modifications, including phosphorylation, acetylation and proline hydroxylation. This workflow was extended to include relative and 'absolute' quantification of post-translational modification levels between samples, and is useful for the sensitive detection of any peptide, particularly in establishing MRM/SRM-type assays for biomarker validation workflows.
In 2011, he took up the post of Proteomics Lead at Central Manchester NHS Foundation Trust as part of the Centre for Advanced Discovery and Experimental Therapeutics (CADET), a joint venture with The University of Manchester. The Centre primarily focussed on the discovery of novel targets for therapeutic intervention, to define key pathways in disease progression, and extend these studies into the development and characterisation of novel therapeutics. As well as standard -omics-type analysis, Richard developed assays for targeted quantification of proteins and small molecules, providing data on pharmacokinaetics on both new and existing medications, and allowing the analysis of novel disease biomarkers in large sample cohorts.
In April 2017, Richard moved back to The University of Manchester to take up a Research Fellowship position in order to pursue his own research into how protein expression levels are altered in diseases, primarily in neurodegenerative disorders such as Alzheimer's Disease.
In April 2019, he was awarded a Senior Lectureship and became Deputy Diector of the Stoller Biomarker Discovery Centre (link)
研究兴趣
论文共 53 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in molecular neuroscience (2023): 1215637
Crystal Sang,Sasha A Philbert, Danielle Hartland,Richard D Unwin,Andrew W Dowsey,Jingshu Xu,Garth J S Cooper
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn